Chong Huang
Key Laboratory Of Drug Targeting And Drug Delivery System Of Ministry Of Education
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Discovery and structure-activity relationship analyses of 1,2-diphenylethane derivatives as a new class of GPR68 antagonists and the therapeutic effect in an inflammatory bowel disease model.
Journal: European journal of medicinal chemistry
Published: December 08, 2025
Giant panda seasonal adaptations in feeding strategies and blood physiology.
Journal: Frontiers in veterinary science
Published: September 11, 2025
YL1004 is a SARS-CoV-2 papain-like protease inhibitor with immunomodulatory and antiviral activity in mice.
Journal: Nature communications
Published: September 01, 2025
The bacterial diversity and potential pathogenic risks of giant panda-infesting ticks.
Journal: Microbiology spectrum
Published: June 10, 2025
Low Reproductivity of Giant Pandas May Be Associated with Increased Vaginal Escherichia-Shigella.
Journal: Microorganisms
Published: October 22, 2024
Efficacy of azithromycin combined with compounded atovaquone in treating babesiosis in giant pandas.
Efficacy of azithromycin combined with compounded atovaquone in treating babesiosis in giant pandas.
Journal: Parasites & vectors
Published: October 15, 2024
Discovery of α-Ketoamide inhibitors of SARS-CoV-2 main protease derived from quaternized P1 groups.
Journal: Bioorganic chemistry
Published: October 20, 2023
Discovery and structure-activity relationship studies of novel α-ketoamide derivatives targeting the SARS-CoV-2 main protease.
Journal: European journal of medicinal chemistry
Published: May 30, 2023
Discovery of 4-(1,2,4-Oxadiazol-5-yl)azepan-2-one Derivatives as a New Class of Cannabinoid Type 2 Receptor Agonists for the Treatment of Inflammatory Pain.
Journal: Journal of medicinal chemistry
Published: February 23, 2023
A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variants.
Journal: Signal transduction and targeted therapy
Published: February 04, 2023
Last Updated: 09/26/2026